References
- 1. Silversides JA, Lappin E, Ferguson AJ. Staphylococcal Toxic Shock Syndrome: Mechanisms and Management. Curr Infect Dis Rep. 2010;12:392-400.
- 2. Amagai M, Yamaguchi T, Hanakawa Y, Nishifuji K, Sugai M, Stanley JR. Staphylococcal exfoliative toxin B specifically cleaves desmoglein. J Invest Dermatol. 2002;118:845-50.
- 3. Hanakawa Y, Stanley JR. Mechanisms of blister formation by staphylococcal toxins. J Biochem. 2004;136:747-50.
- 4. Ladhani S. Understanding the mechanism of action of the exfoliative toxins of Staphylococcus aureus. FEMS Immunol Med Microbiol. 2003;39:181-9.
- 5. Uchiyama T, Yan X-J, Imanishi K, Yagi J. Bacterial superantigens-mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases. Microbiol Immunol. 1994;38:245–56.
- 6. Uchiyama T, Imanishi K, Miyoshi-Akiyama T, Kato H. Staphylococcal superantigens and diseases caused by them. In: Alouf JE, Popoff MR: The Comprehensive Sourcebook of Bacterial Protein Toxins, 3rd Edition. New York: Elsevier.2006;830–43.
- 7. Adalat S, Dawson T, Hackett SJ, Clark JE. In association with the British Paediatric Surveillance Unit. Toxic shock syndrome surveillance in UK children. Arch Dis Child. 2014;99:1078-82.
- 8. Decleire PY, Blondiaux G, Delaere B, Glupczynski Y. Staphyloccocal scalded skin syndrome in an adult. Acta Clin Belg. 2004;59:365-8.
- 9. Oono T, Kanzaki H, Yoshioka T, Arata J. Staphylococcal scalded skin syndrome in an adult. Identification of exfoliative toxin A and B genes by polymerase chain reaction. Dermatology. 1997;195:268-70.
- 10. Shirin S, Gottlieb AB, Stahl EB. Staphylococcal scalded skin syndrome in an immunocompetent adult: possible implication of low-dosage prednisone. Cutis. 1998;62:223-4.
- 11. Centers for Disease Control and Prevention. Toxic shock syndrome (other than Streptococcal) (TSS): 2011 Case Definition. 2014.
- 12. Chuang YY, Huang YC, Lin TY. Toxic shock syndrome in children: epidemiology, pathogenesis, and management. Paediatr Drugs. 2005;7:11-25.
- 13. Takahashi N, Hasegawa H, Komiyama M, et al. Selective excretion of anti-inflammatory cytokine interleukin-10 in a superantigen-inducing neonatal infectious disease. Cytokine. 2009;45:39–43.
- 14. Takahashi N, Imanishi K, Uchiyama T. Overall picture of an emerging neonatal infectious disease induced by a superantigenic exotoxin mainly produced by methicillin-resistant Staphylococcus aureus. Microbiol Immunol. 2013;57:737-45.